Astellas Venture Management logo

Astellas Venture Management

North America, California, United States, Menlo Park

Description

Astellas Venture Management is a California-based financial organization that targets investments in the biotechnology sector.

Investor Profile

Astellas Venture Management has made 66 investments, with 2 in the past 12 months and 12% as lead.

Stage Focus

  • Series A (33%)
  • Series B (32%)
  • Series Unknown (18%)
  • Series C (6%)
  • Seed (5%)
  • Series D (3%)
  • Series E (2%)
  • Pre Seed (2%)

Country Focus

  • United States (65%)
  • United Kingdom (24%)
  • Japan (8%)
  • Canada (2%)
  • Switzerland (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Biopharma
  • Life Science
  • Genetics
  • Medical Device
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Astellas Venture Management frequently co-invest with?

Abingworth
Europe, England, United Kingdom, London
Co-Investments: 4
Amgen Ventures
North America, California, United States, San Francisco
Co-Investments: 5
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 13
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 12
Longwood Fund
North America, Massachusetts, United States, Boston
Co-Investments: 7
SR One
North America, Massachusetts, United States, Cambridge
Co-Investments: 5
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 4
OUP (Osage University Partners)
North America, Pennsylvania, United States, Bala Cynwyd
Co-Investments: 7
U.S. Venture Partners
North America, California, United States, Menlo Park
Co-Investments: 6
Sofinnova Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 5

Which angels does Astellas Venture Management often collaborate with?

DD
Europe, Cambridgeshire, United Kingdom, Cambridge
Shared Deals: 1
JM
North America, Massachusetts, United States, Cambridge
Shared Deals: 4

What are some of recent deals done by Astellas Venture Management?

SyntaxBio

Chicago, Illinois, United States

SyntaxBio develops genetic programming platform that can program cells without the need for consistent external intervention.

BiotechnologyMedicalProduct Research
SeedSep 17, 2024
PhoreMost

Cambridge, Cambridgeshire, United Kingdom

PhoreMost is a new-model drug discovery company based in Cambridge, UK.

BiopharmaBiotechnologyHealth Care
Series BSep 12, 2024
Amount Raised: $12,000,000
NeoPhore

Cambridge, Cambridgeshire, United Kingdom

NeoPhore is a provider of novel small molecule therapies intended to treat cancer through stimulation of the immune system.

BiotechnologySimulationTherapeuticsTranslation Service
Series BFeb 1, 2024
Amount Raised: $12,236,423
Shinobi Therapeutics

South San Francisco, California, United States

Shinobi Therapeutics develops immune-evasive iPS cell therapies for cancer treatment.

BiotechnologyHealth CareTherapeutics
Series ADec 12, 2023
Amount Raised: $51,000,000
Mogrify

Cambridge, Cambridgeshire, United Kingdom

Mogrify® will transform the lives of patients with degenerative diseases through a novel class of in vivo reprogramming therapies.

Big DataBioinformaticsBiotechnologyHealth CareLife ScienceTherapeutics
Series AOct 2, 2023
Amount Raised: $10,000,000
Solu Therapeutics

Boston, Massachusetts, United States

Solu Therapeutics is a precision-medicine-focused company developing therapeutics to eliminate disease-driving cells.

BiotechnologyTherapeutics
SeedAug 1, 2023
Amount Raised: $31,000,000
Avilar Therapeutics

Waltham, Massachusetts, United States

Avilar Therapeutics is a biopharmaceutical company focusing on extracellular protein degradation.

BiotechnologyMedicalPharmaceutical
SeedFeb 16, 2023
Amount Raised: $15,000,000
NeoPhore

Cambridge, Cambridgeshire, United Kingdom

NeoPhore is a provider of novel small molecule therapies intended to treat cancer through stimulation of the immune system.

BiotechnologySimulationTherapeuticsTranslation Service
Series BJan 19, 2023
Amount Raised: $7,435,460
Casma Therapeutics

Cambridge, Massachusetts, United States

Casma Therapeutics is a biotechnology company harnessing the natural cellular process of autophagy to design new medicines.

BiotechnologyHealth CareTherapeutics
Series CNov 15, 2022
Amount Raised: $46,000,000
DEM BioPharma

Cambridge, Massachusetts, United States

DEM BioPharma is an immuno-oncology company that is working to eradicate cancer by targeting novel innate immune system checkpoints.

BiotechnologyLife ScienceOncologyPharmaceutical
Series AJun 23, 2022
Amount Raised: $70,000,000